This research aims to explore the dynamics of donor-derived stem cell memory CAR T cells following relapse after allogeneic hematopoietic stem cell transplantation (HSCT).
Examined in vivo dynamics of CAR T cells using a randomized trial design.
Evaluated outcomes in patients post-allogeneic HSCT.
Measured cell behavior across different time points after relapse.
Donor-derived CAR T cells exhibited unique in vivo dynamics compared to traditional T cells.
Significant differences in memory cell responses were observed during patient relapse phases.
Implications suggest a need for tailored CAR T therapy approaches based on these dynamic responses.
Abstract
cells as a promising platform for next-generation CAR T cell therapies.